Sustained Remission in Tumor Necrosis Factor Inhibitor-treated Patients with Rheumatoid Arthritis: A Population-based Cohort Study.
Research output: Contribution to journal › Article
To study frequency, possible baseline predictors, timing, and duration of sustained remission [SR; defined as 28-joint Disease Activity Score (DAS28) < 2.6 for at least 6 mos] in patients with established rheumatoid arthritis (RA) treated with different tumor necrosis factor (TNF) inhibitors [etanercept (ETN), infliximab (IFX), adalimumab (ADA)]. In addition, the aim was to compare (head-to-head) the effectiveness of individual drugs in patients receiving their first anti-TNF treatment.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Journal||Journal of Rheumatology|
|Publication status||Published - 2015|
Related research output
Jon Thorkell Einarsson, 2018, Lund: Lund University: Faculty of Medicine. 103 p.
Research output: Thesis › Doctoral Thesis (compilation)